Contract analysis

I. Executive Summary The purpose of this memorandum is to analyze the risk that the Internal Revenue Service may attempt to recharacterize elements of Penterra Pharmaceuticals Corp.'s ("PPC") cost-sharing arrangement ("CSA") with Penterra Biopharma International DAC ("PBI") as an outbound transfer of intangible property subject to IRC § 367(d), rather than — or in addition to — making adjustments under IRC § 482. Thi

II. Factual Background A. Corporate Structure Penterra Pharmaceuticals Corp. ("PPC") is a Delaware corporation, publicly traded on the Nasdaq Stock Market under the ticker symbol "PPCA," and headquartered at 2200 Independence Boulevard, Princeton Junction, New Jersey 08550. PPC is a specialty pharmaceuticals and biotechnology company focused on oncology, immunology, and rare disease therapeutics. For fiscal year 2020

1. CSA Cost-Sharing Ratio Adjustments. The IRS is proposing to increase PBI's cost-sharing percentages by approximately 8 to 12 percentage points across the examination years, arguing that PBI's reasonably anticipated benefits were higher than the ratios employed by PPC.

2. Legacy IP Royalty Rate Adjustment. The IRS is proposing to increase the legacy IP royalty rate from 4.5% to 11.0% of net sales, based on comparable uncontrolled transaction analysis and the IRS's view that PPC's pre-existing IP was significantly more valuable than reflected in the existing royalty rate.

3. Economic Substance of PBI. The IRS has questioned whether PBI possesses sufficient DEMPE functions and whether key decision-making and intangible development functions remained in the United States, which would support either a reallocation of income under § 482 or, potentially, a recharacterization of the arrangement. No formal Notice of Proposed Adjustment ("NOPA") asserting a § 367(d) position has been issued a

III. Legal Framework — IRC § 367(d) A. Statutory Text and Purpose IRC § 367(d) was enacted to address the concern that U.S. taxpayers could transfer valuable intangible property to controlled foreign corporations in tax-free exchanges — thereby shifting future income derived from those intangibles to low-tax jurisdictions — without adequate recognition of gain or ongoing compensation to the U.S. transferor. The provi

IV. The CSA/PCT as Distinguished from a § 367(d) Transfer A. Structural Analysis: CSA vs. Outbound IP Transfer The fundamental structural distinction between PPC's CSA with PBI and an outbound transfer of intangible property subject to § 367(d) is that the CSA is a contractual cost-sharing arrangement governed by Treasury Regulation § 1.482-7, not a contribution of property to a controlled foreign corporation under §

V. Risk Assessment: Potential § 367(d) Recharacterization Theories We have identified four potential theories under which the IRS could attempt to apply § 367(d) to PPC's CSA with PBI. For each theory, we describe the analytical basis, assess the likelihood and potential impact, and evaluate the available defenses. A. Theory 1: Recharacterization of the CSA as a Sham or Lacking Economic Substance The most significant

VI. Interplay Between § 367(d) and § 482 A. Overlap and Potential Double Taxation Both IRC § 367(d) and IRC § 482 address the pricing and taxation of intangible property transfers between controlled U.S. and foreign entities. This overlap creates a potential for double taxation if both provisions were applied to the same intangible property and the same transaction. The coordination rule under Treasury Regulation § 1

VII. Impact of PHL's Disregarded Entity Status PHL, the Luxembourg intermediate holding company through which PPC holds its 100% ownership interest in PBI, is treated as a disregarded entity for U.S. federal income tax purposes. The practical implications of this treatment for the § 367(d) analysis are straightforward but worth stating clearly. Because PHL is disregarded, PPC is treated as the direct owner of PBI. An

VIII. TCJA Considerations The Tax Cuts and Jobs Act ("TCJA"), enacted December 22, 2017, and generally effective January 1, 2018, introduced several provisions that bear on the § 367(d) analysis for the portion of the examination period covering TY 2018, 2019, and 2020. Corporate Tax Rate Reduction. The TCJA reduced the corporate income tax rate from 35% to 21%, effective for tax years beginning after December 31, 20

IX. Case Law and Precedent A. Key Cases While there is no single case directly addressing the application of § 367(d) to a properly structured QCSA with an arm's-length PCT payment, several significant Tax Court and appellate decisions inform the analysis of the boundary between § 367(d) and § 482 in the cost-sharing arrangement context. Altera Corp. v. Commissioner. In Altera Corp. v. Commissioner, 145 T.C. 91 (2015